Key result
Clarithromycin added to sulfonylureas is linked to severe hypoglycemia within 48 hours.
Why the study?
The interaction between clarithromycin and sulfonylureas causing severe hypoglycemia had not been previously reported in elderly patients with type 2 diabetes.
Does the addition of clarithromycin to sulfonylurea therapy cause severe hypoglycemia in elderly patients with type 2 diabetes?
Case Report (n=2)
Does the addition of clarithromycin to sulfonylurea therapy cause severe hypoglycemia in elderly patients with type 2 diabetes?
Clarithromycin can interact with sulfonylureas to cause severe, potentially life-threatening hypoglycemia in elderly patients with type 2 diabetes and impaired renal function.
Answers are grounded in this paper and cite their sources.
Potential interaction warrants caution with clarithromycin and sulfonylureas in elderly patients; leaves open confirmation in larger studies.
We report two cases of severe hypoglycemia occurring in elderly men with type 2 diabetes who were prescribed clarithromycin for respiratory infections. Both individuals had well-controlled diabetes and mild to moderately impaired renal function. Both individuals were prescribed clarithromycin in identical dosages and both developed severe hypoglycemia within 48 h of starting the antibiotic. Although many drugs have been reported to interact with sulfonylureas causing hypoglycemia, the interaction between clarithromycin and a sulfonylurea has not been previously reported. We discuss the suspected mechanism for this potentially severe reaction which is of concern in the treatment of elderly patients with type 2 diabetes. An 82-year-old white male with a 4-month history of type 2 diabetes was treated with diet and glyburide 5 mg daily. His blood glucose readings were in the low 100s (mg/dl). His comorbidities included atherosclerotic heart disease, hypertension, mild chronic renal failure with a creatinine of 1.6 mg/dl, emphysema, and bladder cancer. In a local emergency department (ED), he was diagnosed with “bronchitis” and prescribed clarithromycin, 1,000 mg daily. He became unresponsive with an Accucheck reading of 24 mg/dl, 48 h after starting clarithromycin. Administration of intravenous …
No takes yet. Share an insight, caveat, or question.
Bussing et al. (2002) conducted a case report in Type 2 diabetes (n=2). Clarithromycin was evaluated on Severe hypoglycemia. Coadministration of clarithromycin in two elderly men with type 2 diabetes treated with a sulfonylurea resulted in severe hypoglycemia within 48 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: